Insight Molecular Diagnostics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $30.8M | $22.1M |
| FY2020 | — | $33.5M | $7.1M |
| FY2021 | — | $65.2M | $32.9M |
| FY2022 | — | $34.3M | $20.0M |
| FY2023 | — | $20.5M | $9.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $30.8M | $22.1M |
| FY2020 | — | $33.5M | $7.1M |
| FY2021 | — | $65.2M | $32.9M |
| FY2022 | — | $34.3M | $20.0M |
| FY2023 | — | $20.5M | $9.4M |